Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cell therapy
Biotech
Immatics leaps into phase 3 on strength of early-stage PFS data
Immatics is starting a pivotal trial of its melanoma cell therapy in light of the response and PFS results seen in a phase 1b study.
Nick Paul Taylor
Oct 10, 2024 8:49am
Astellas telegraphs new cell therapy site in Japan, 24 US layoffs
Oct 9, 2024 5:45pm
Zephyrm seeks Hong Kong IPO to fund phase 3 cell therapy trials
Oct 2, 2024 8:19am
BMS pays Prime $110M to form T-cell therapy pact
Sep 30, 2024 7:18am
Achilles drops cell therapy program, braces for layoffs
Sep 19, 2024 9:24am
New cell therapy biotech emerges from the lab of George Church
Sep 19, 2024 6:30am
